
News
Filter Results
Displaying 11–20 of 519
-
May 9, 2025
The company is currently enrolling patients in its Phase 2/3 VISTA Clinical Trial.
-
May 1, 2025
The Foundation Fighting Blindness develops strategic partnership with Alma, a network of 25,000 mental health professionals dedicated to simplifying access to high-quality, affordable mental healthcare.
-
Apr 25, 2025
The Foundation Fighting Blindness and the Retinal Degeneration Fund (RD Fund) hosted their annual Investing in Cures Summit (ICS) on March 21 and 22, 2025 in Tampa to highlight the strong progress in development of treatments and cures for the entire spectrum of retinal degenerative diseases.
-
Apr 11, 2025
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Apr 11, 2025
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Apr 11, 2025
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
-
Apr 11, 2025
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Apr 11, 2025
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Apr 10, 2025
The partnership will formalize an ongoing commitment by both companies to accelerate the development of treatments and cures for retinal diseases, while prioritizing a patient-centric approach.
-
Apr 7, 2025
Atsena Receives $150 Million in New Financing to Advance XLRS and Preclinical Gene Therapy Programs
The company has reported encouraging results from its LCA1 and XLRS gene therapy clinical trials.